Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 148297, 11 pages
http://dx.doi.org/10.1155/2013/148297
Research Article

Enhancement of Lymphangiogenesis In Vitro via the Regulations of HIF-1 Expression and Nuclear Translocation by Deoxyshikonin

1Department of Kampo Diagnostics, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan
2Department of Biopharmacy, Faculty of Pharmacy, Srinakharinwirot University, Nakhonnayok 26120, Thailand

Received 11 January 2013; Revised 19 March 2013; Accepted 21 March 2013

Academic Editor: Ken Yasukawa

Copyright © 2013 Orawin Prangsaengtong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Tammela and K. Alitalo, “Lymphangiogenesis: molecular mechanisms and future promise,” Cell, vol. 140, no. 4, pp. 460–476, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. L. N. Cueni and M. Detmar, “The lymphatic system in health and disease,” Lymphatic Research and Biology, vol. 6, no. 3-4, pp. 109–122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Roskoski Jr., “Vascular endothelial growth factor (VEGF) signaling in tumor progression,” Critical Reviews in Oncology/Hematology, vol. 62, no. 3, pp. 179–213, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. C. Brahimi-Horn and J. Pouysségur, “HIF at a glance,” Journal of Cell Science, vol. 122, no. 8, pp. 1055–1057, 2009. View at Google Scholar
  5. A. Kuschel, P. Simon, and S. Tug, “Functional regulation of HIF-1α under normoxia—is there more than post-translational regulation?” Journal of Cellular Physiology, vol. 227, no. 2, pp. 514–524, 2012. View at Google Scholar
  6. J. Jośko and M. Mazurek, “Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis,” Medical Science Monitor, vol. 10, no. 4, pp. RA89–RA98, 2004. View at Google Scholar · View at Scopus
  7. J. C. Zampell, A. Yan, T. Avraham, S. Daluvoy, E. S. Weitman, and B. J. Mehrara, “HIF-1α coordinates lymphangiogenesis during wound healing and in response to inflammation,” The FASEB Journal, vol. 26, no. 3, pp. 1027–1039, 2012. View at Google Scholar
  8. J. P. Bridges, S. Lin, M. Ikegami, and J. M. Shannon, “Conditional hypoxia inducible factor-1α induction in embryonic pulmonary epithelium impairs maturation and augments lymphangiogenesis,” Developmental Biology, vol. 362, no. 1, pp. 24–41, 2012. View at Google Scholar
  9. T. Hisa, Y. Kimura, K. Takada, F. Suzuki, and M. Takigawa, “Shikonin, an ingredient of Lithospermum erythrorhizon, inhibits angiogenesis in vivo and in vitro,” Anticancer Research, vol. 18, no. 2A, pp. 783–790, 1998. View at Google Scholar · View at Scopus
  10. P. J. Lu, C. Yang, C. N. Lin et al., “Shiunko and acetylshikonin promote reepithelialization, angiogenesis, and granulation tissue formation in wounded skin,” American Journal of Chinese Medicine, vol. 36, no. 1, pp. 115–123, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. G. C. Gurtner, S. Werner, Y. Barrandon, and M. T. Longaker, “Wound repair and regeneration,” Nature, vol. 453, no. 7193, pp. 314–321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Chen, L. Yang, J. J. Oppenheim, and O. M. Z. Howard, “Cellular pharmacology studies of shikonin derivatives,” Phytotherapy Research, vol. 16, no. 3, pp. 199–209, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. H. J. Lee, H. J. Lee, V. Magesh et al., “Shikonin, acetylshikonin, and isobutyroylshikonin inhibit VEGF-induced angiogenesis and suppress tumor growth in Lewis lung carcinoma-bearing mice,” Yakugaku Zasshi, vol. 128, no. 11, pp. 1681–1688, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Prangsaengtong, K. Koizumi, K. Senda, H. Sakurai, and I. Saiki, “ENOS and Hsp90 interaction directly correlates with cord formation in human lymphatic endothelial cells,” Lymphatic Research and Biology, vol. 9, no. 1, pp. 53–59, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Andrae, E. Kirches, R. Hartig et al., “Sunitinib targets PDGF-receptor and Flt3 and reduces survival and migration of human meningioma cells,” European Journal of Cancer, vol. 48, no. 12, pp. 1831–1841, 2012. View at Google Scholar
  16. Y. Komi, Y. Suzuki, M. Shimamura et al., “Mechanism of inhibition of tumor angiogenesis by β-hydroxyisovalerylshikonin,” Cancer Science, vol. 100, no. 2, pp. 269–277, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Vega-Diaz, G. S. Herron, and S. Michel, “An autocrine loop mediates expression of vascular endothelial growth factor in human dermal microvascular endothelial cells,” Journal of Investigative Dermatology, vol. 116, no. 4, pp. 525–530, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. M. J. Karkkainen, P. Haiko, K. Sainio et al., “Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins,” Nature Immunology, vol. 5, no. 1, pp. 74–80, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. S. J. Mandriota, L. Jussila, M. Jeltsch et al., “Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis,” The EMBO Journal, vol. 20, no. 4, pp. 672–682, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. S. F. Schoppmann, A. Fenzl, M. Schindl et al., “Hypoxia inducible factor-1α correlates with VEGF-C expression and lymphangiogenesis in breast cancer,” Breast Cancer Research and Treatment, vol. 99, no. 2, pp. 135–141, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Liang, D. Yang, J. Hu, X. Hao, J. Gao, and Z. Mao, “Hypoxia inducible factor-1alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma,” Anticancer Research, vol. 28, no. 3A, pp. 1659–1666, 2008. View at Google Scholar · View at Scopus
  22. K. Maruyama, J. Asai, M. Ii, T. Thorne, D. W. Losordo, and P. A. D'Amore, “Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing,” American Journal of Pathology, vol. 170, no. 4, pp. 1178–1191, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Sasaki, H. Abe, and F. Yoshizaki, “In vitro antifungal activity of naphthoquinone derivatives,” Biological and Pharmaceutical Bulletin, vol. 25, no. 5, pp. 669–670, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Rajasekar, D. J. Park, C. Park et al., “In vitro and in vivo anticancer effects of Lithospermum erythrorhizon extract on B16F10 murine melanoma,” Journal of Ethnopharmacology, vol. 144, no. 2, pp. 335–345, 2012. View at Google Scholar
  25. Y. Xuan and X. Hu, “Naturally-occurring shikonin analogues—a class of necroptotic inducers that circumvent cancer drug resistance,” Cancer Letters, vol. 274, no. 2, pp. 233–242, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. H. K. Kleinman and G. R. Martin, “Matrigel: basement membrane matrix with biological activity,” Seminars in Cancer Biology, vol. 15, no. 5, pp. 378–386, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. D. H. Ausprunk and J. Folkman, “Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis,” Microvascular Research, vol. 14, no. 1, pp. 53–65, 1977. View at Google Scholar · View at Scopus
  28. S. Dias, M. Choy, K. Alitalo, and S. Rafii, “Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy,” Blood, vol. 99, no. 6, pp. 2179–2184, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Detmar, “Molecular regulation of angiogenesis in the skin,” Journal of Investigative Dermatology, vol. 106, no. 2, pp. 207–208, 1996. View at Google Scholar · View at Scopus
  30. A. Görlach and S. Bonello, “The cross-talk between NF-kappaB and HIF-1: further evidence for a significant liaison,” The Biochemical Journal, vol. 412, no. 3, pp. e17–e19, 2008. View at Google Scholar · View at Scopus
  31. G. L. Semenza, M. K. Nejfelt, S. M. Chi, and S. E. Antonarakis, “Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 13, pp. 5680–5684, 1991. View at Publisher · View at Google Scholar · View at Scopus
  32. C. V. Dang, J. W. Kim, P. Gao, and J. Yustein, “The interplay between MYC and HIF in cancer,” Nature Reviews Cancer, vol. 8, no. 1, pp. 51–56, 2008. View at Publisher · View at Google Scholar · View at Scopus